Nathans Famous Inc NATH Q4 2024 Earnings EPS of 096 Despite Quiet Quarter Stock Edges Lower PAGP Q1 2026 Earnings Massive EPS Surprise Highlights Resilient Midstream Operations PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response YPF Q4 2025 Earnings Substantial Loss Reported Stock Climbs Amid Unusual Results WHLRP Q2 2024 Earnings Positive EPS Surprise Amid Steep Stock Decline RMTI Q1 2026 Earnings EPS Falls Short as Loss Narrows but Misses Estimates